These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33214497)

  • 61. An Oxygenated and Transportable Machine Perfusion System Fully Rescues Liver Grafts Exposed to Lethal Ischemic Damage in a Pig Model of DCD Liver Transplantation.
    Compagnon P; Levesque E; Hentati H; Disabato M; Calderaro J; Feray C; Corlu A; Cohen JL; Ben Mosbah I; Azoulay D
    Transplantation; 2017 Jul; 101(7):e205-e213. PubMed ID: 28403128
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In situ splitting of cadaveric livers. The ultimate expansion of a limited donor pool.
    Rogiers X; Malagó M; Gawad K; Jauch KW; Olausson M; Knoefel WT; Gundlach M; Bassas A; Fischer L; Sterneck M; Burdelski M; Broelsch CE
    Ann Surg; 1996 Sep; 224(3):331-9; discussion 339-41. PubMed ID: 8813261
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Outcomes of liver transplantation with liver grafts from pediatric donors used in adult recipients.
    Croome KP; Lee DD; Burns JM; Saucedo-Crespo H; Perry DK; Nguyen JH; Taner CB;
    Liver Transpl; 2016 Aug; 22(8):1099-106. PubMed ID: 27145067
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Liver Xenotransplantation in a Nonhuman Primate Model.
    Navarro-Alvarez N; Vagefi PA
    Methods Mol Biol; 2020; 2110():197-211. PubMed ID: 32002910
    [TBL] [Abstract][Full Text] [Related]  

  • 65. High serum Aspartate transaminase levels on day 3 postliver transplantation correlates with graft and patient survival and would be a valid surrogate for outcome in liver transplantation clinical trials.
    Robertson FP; Bessell PR; Diaz-Nieto R; Thomas N; Rolando N; Fuller B; Davidson BR
    Transpl Int; 2016 Mar; 29(3):323-30. PubMed ID: 26615011
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Incidence, impact, and treatment of portal and hepatic venous complications following pediatric liver transplantation: a single-center 12 year experience.
    Heffron TG; Pillen T; Smallwood G; Henry S; Sekar S; Casper K; Solis D; Tang W; Fasola C; Romero R
    Pediatr Transplant; 2010 Sep; 14(6):722-9. PubMed ID: 20345612
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
    McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
    Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Postreperfusion hyperkalemia in liver transplantation using donation after cardiac death grafts with pathological changes.
    Zhang WJ; Xia WL; Pan HY; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2016 Oct; 15(5):487-492. PubMed ID: 27733317
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Functional analysis of grafts from living donors. Implications for the treatment of older recipients.
    Emond JC; Renz JF; Ferrell LD; Rosenthal P; Lim RC; Roberts JP; Lake JR; Ascher NL
    Ann Surg; 1996 Oct; 224(4):544-52; discussion 552-4. PubMed ID: 8857858
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Split-liver transplantation for two adult recipients: feasibility and long-term outcomes.
    Azoulay D; Castaing D; Adam R; Savier E; Delvart V; Karam V; Ming BY; Dannaoui M; Krissat J; Bismuth H
    Ann Surg; 2001 Apr; 233(4):565-74. PubMed ID: 11303140
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Transjugular intrahepatic portosystemic stent-shunt and its effects on orthotopic liver transplantation.
    Tripathi D; Therapondos G; Redhead DN; Madhavan KK; Hayes PC
    Eur J Gastroenterol Hepatol; 2002 Aug; 14(8):827-32. PubMed ID: 12172401
    [TBL] [Abstract][Full Text] [Related]  

  • 72. High Intrapatient Variability in Tacrolimus Exposure Is Not Associated With Immune-mediated Graft Injury After Liver Transplantation.
    van der Veer MAA; Nangrahary N; Hesselink DA; Erler NS; Metselaar HJ; van Gelder T; Darwish Murad S
    Transplantation; 2019 Nov; 103(11):2329-2337. PubMed ID: 30801539
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Minimum graft size calculated from preoperative recipient status in living donor liver transplantation.
    Marubashi S; Nagano H; Eguchi H; Wada H; Asaoka T; Tomimaru Y; Tomokuni A; Umeshita K; Doki Y; Mori M
    Liver Transpl; 2016 May; 22(5):599-606. PubMed ID: 26684397
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Histopathology of the donor gallbladder removed at orthotopic liver transplantation: correlation with graft function.
    Khettry U; Dwarakanath S; Pinson CW; Jenkins RL; Arkin CF
    Hum Pathol; 1991 May; 22(5):437-41. PubMed ID: 2032693
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The UK DCD Risk Score: A new proposal to define futility in donation-after-circulatory-death liver transplantation.
    Schlegel A; Kalisvaart M; Scalera I; Laing RW; Mergental H; Mirza DF; Perera T; Isaac J; Dutkowski P; Muiesan P
    J Hepatol; 2018 Mar; 68(3):456-464. PubMed ID: 29155020
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Auxiliary partial orthotopic liver transplantation for fulminant hepatitis. The Paul Brousse experience.
    Bismuth H; Azoulay D; Samuel D; Reynes M; Grimon G; Majno P; Castaing D
    Ann Surg; 1996 Dec; 224(6):712-24; discussion 724-6. PubMed ID: 8968226
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Outcomes of adult-to-adult living donor liver transplantation in 321 recipients.
    Uchiyama H; Shirabe K; Kimura K; Yoshizumi T; Ikegami T; Harimoto N; Maehara Y
    Liver Transpl; 2016 Mar; 22(3):305-15. PubMed ID: 26610068
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Portal venous pressure and proper graft function in living donor liver transplants in 69 patients from an Egyptian center.
    Sholkamy A; Salman A; El-Garem N; Hosny K; Abdelaziz O
    Ann Saudi Med; 2018; 38(3):181-188. PubMed ID: 29848935
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Donor graft adenoviral iNOS gene transfer ameliorates rat liver transplant preservation injury and improves survival.
    Kaizu T; Ikeda A; Nakao A; Takahashi Y; Tsung A; Kohmoto J; Toyokawa H; Shao L; Bucher BT; Tomiyama K; Nalesnik MA; Murase N; Geller DA
    Hepatology; 2006 Mar; 43(3):464-73. PubMed ID: 16496305
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Auxiliary partial liver transplantation for acute liver failure using "high risk" grafts: Case report.
    Duan WD; Wang XT; Wang HG; Ji WB; Li H; Dong JH
    World J Gastroenterol; 2016 Feb; 22(5):1919-24. PubMed ID: 26855552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.